These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3778935)
41. Hitchhiking nanoparticles: Reversible coupling of lipid-based nanoparticles to cytotoxic T lymphocytes. Wayteck L; Dewitte H; De Backer L; Breckpot K; Demeester J; De Smedt SC; Raemdonck K Biomaterials; 2016 Jan; 77():243-54. PubMed ID: 26606450 [TBL] [Abstract][Full Text] [Related]
42. Small, but not large, unilamellar liposomes composed of dioleoylphosphatidylethanolamine and oleic acid can be stabilized by human plasma. Liu DX; Huang L Biochemistry; 1989 Sep; 28(19):7700-7. PubMed ID: 2611208 [TBL] [Abstract][Full Text] [Related]
43. Structural and functional comparisons of pH-sensitive liposomes composed of phosphatidylethanolamine and three different diacylsuccinylglycerols. Collins D; Litzinger DC; Huang L Biochim Biophys Acta; 1990 Jun; 1025(2):234-42. PubMed ID: 2364079 [TBL] [Abstract][Full Text] [Related]
44. Chronic liposome administration in mice: effects on reticuloendothelial function and tissue distribution. Allen TM; Murray L; MacKeigan S; Shah M J Pharmacol Exp Ther; 1984 Apr; 229(1):267-75. PubMed ID: 6707942 [TBL] [Abstract][Full Text] [Related]
45. Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model. Storm G; Roerdink FH; Steerenberg PA; de Jong WH; Crommelin DJ Cancer Res; 1987 Jul; 47(13):3366-72. PubMed ID: 3581073 [TBL] [Abstract][Full Text] [Related]
46. Preparation and antitumor effect of macrophage activating factor (MAF) encapsulated in liposomes bearing a monoclonal anti-human melanoma (A375) antibody. Watanabe Y; Uchida E; Higuchi M; Imai Y; Osawa T J Biol Response Mod; 1987 Oct; 6(5):556-68. PubMed ID: 3316511 [TBL] [Abstract][Full Text] [Related]
49. Sonosensitive dioleoylphosphatidylethanolamine-containing liposomes with prolonged blood circulation time of doxorubicin. Evjen TJ; Hagtvet E; Nilssen EA; Brandl M; Fossheim SL Eur J Pharm Sci; 2011 Jul; 43(4):318-24. PubMed ID: 21620968 [TBL] [Abstract][Full Text] [Related]
50. Liposomes composed of dioleoylphosphatidylethanolamine and 2-(hexadecyloxy)cinnamic acid: effects of UV irradiation and pH value on release. Seo HJ; Kim JC J Nanosci Nanotechnol; 2013 Mar; 13(3):1727-32. PubMed ID: 23755580 [TBL] [Abstract][Full Text] [Related]
51. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy. Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702 [TBL] [Abstract][Full Text] [Related]
52. Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties. Krishna R; Webb MS; St Onge G; Mayer LD J Pharmacol Exp Ther; 2001 Sep; 298(3):1206-12. PubMed ID: 11504822 [TBL] [Abstract][Full Text] [Related]
53. Grafting of different glycosides on the surface of liposomes and its effect on the tissue distribution of 125I-labelled gamma-globulin encapsulated in liposomes. Ghosh P; Bachhawat BK Biochim Biophys Acta; 1980 Nov; 632(4):562-72. PubMed ID: 6159929 [TBL] [Abstract][Full Text] [Related]
54. Free fatty acids cause pH-dependent changes in drug-lipid membrane interactions around physiological pH. Krämer SD; Jakits-Deiser C; Wunderli-Allenspach H Pharm Res; 1997 Jun; 14(6):827-32. PubMed ID: 9210205 [TBL] [Abstract][Full Text] [Related]
55. Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody. Hashimoto Y; Sugawara M; Masuko T; Hojo H Cancer Res; 1983 Nov; 43(11):5328-34. PubMed ID: 6616468 [TBL] [Abstract][Full Text] [Related]
56. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160 [TBL] [Abstract][Full Text] [Related]
57. Assessment of the potential uses of liposomes for lymphoscintigraphy and lymphatic drug delivery. Failure of 99m-technetium marker to represent intact liposomes in lymph nodes. Patel HM; Boodle KM; Vaughan-Jones R Biochim Biophys Acta; 1984 Sep; 801(1):76-86. PubMed ID: 6087919 [TBL] [Abstract][Full Text] [Related]
58. [Biodistribution and hepatocytes targeting of cationic liposomes surface-modified with sterylglucoside and golyethylene glycol]. Shi J; Yan WW; Qi XR; Yang L; Zhang L Yao Xue Xue Bao; 2004 Jul; 39(7):551-5. PubMed ID: 15493849 [TBL] [Abstract][Full Text] [Related]
59. Liposomes radiolabeled with (159)Gd: in vitro antitumoral activity, biodistribution study and scintigraphic image in Ehrlich tumor bearing mice. Soares DC; de Oliveira MC; de Barros AL; Cardoso VN; Ramaldes GA Eur J Pharm Sci; 2011 Jul; 43(4):290-6. PubMed ID: 21605669 [TBL] [Abstract][Full Text] [Related]
60. pH-Responsive hyaluronated liposomes for docetaxel delivery. Lee JM; Park H; Oh KT; Lee ES Int J Pharm; 2018 Aug; 547(1-2):377-384. PubMed ID: 29902507 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]